Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults

Prabda Praphasiri, Darunee Ditsungneon, Anusak Kerdsin, Sutthichai Nakphook, Jiraphut Kittiwatanachod, Kanlaya Sornwong, Suriya Naosri, Sarunpattori Khunarsa, Ponthip Wirachwong, Isariya Techatanawat, Piengthong Narakorn, Somchaiya Surichan, Jorge Flores, Laina D. Mercer, Christina S. Polyak, Bruce L. Innis, Rama Raghunandan, Chakrarat Pittayawonganon, Sopon Iamsirithaworn, Supakit Sirilak, Kriengkrai Prasert

Open source

DOI: 10.3390/vaccines14080660
Published: 2026-07-28
Container: Vaccines
Publisher: MDPI AG
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/vaccines14080660,
  title = {Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults},
  author = {Prabda Praphasiri and Darunee Ditsungneon and Anusak Kerdsin and Sutthichai Nakphook and Jiraphut Kittiwatanachod and Kanlaya Sornwong and Suriya Naosri and Sarunpattori Khunarsa and Ponthip Wirachwong and Isariya Techatanawat and Piengthong Narakorn and Somchaiya Surichan and Jorge Flores and Laina D. Mercer and Christina S. Polyak and Bruce L. Innis and Rama Raghunandan and Chakrarat Pittayawonganon and Sopon Iamsirithaworn and Supakit Sirilak and Kriengkrai Prasert},
  year = {2026},
  journal = {Vaccines},
  doi = {10.3390/vaccines14080660},
  url = {https://doi.org/10.3390/vaccines14080660}
}

RIS

TY  - JOUR
TI  - Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults
AU  - Prabda Praphasiri
AU  - Darunee Ditsungneon
AU  - Anusak Kerdsin
AU  - Sutthichai Nakphook
AU  - Jiraphut Kittiwatanachod
AU  - Kanlaya Sornwong
AU  - Suriya Naosri
AU  - Sarunpattori Khunarsa
AU  - Ponthip Wirachwong
AU  - Isariya Techatanawat
AU  - Piengthong Narakorn
AU  - Somchaiya Surichan
AU  - Jorge Flores
AU  - Laina D. Mercer
AU  - Christina S. Polyak
AU  - Bruce L. Innis
AU  - Rama Raghunandan
AU  - Chakrarat Pittayawonganon
AU  - Sopon Iamsirithaworn
AU  - Supakit Sirilak
AU  - Kriengkrai Prasert
PY  - 2026
JO  - Vaccines
DO  - 10.3390/vaccines14080660
UR  - https://doi.org/10.3390/vaccines14080660
ER  -

APA

Praphasiri, P., Ditsungneon, D., Kerdsin, A., Nakphook, S., Kittiwatanachod, J., Sornwong, K., Naosri, S., Khunarsa, S., Wirachwong, P., Techatanawat, I., Narakorn, P., Surichan, S., Flores, J., Mercer, L. D., Polyak, C. S., Innis, B. L., Raghunandan, R., Pittayawonganon, C., Iamsirithaworn, S., Sirilak, S., & Prasert, K. (2026). Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults. Vaccines. https://doi.org/10.3390/vaccines14080660

Source records

crossref · retrieved 2026-09-26T08:36:19.552Z